biblio
, “Triazole-diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking”, MedChemComm, vol. 9, no. 7, pp. 1114-1130, 2018.
, “Ultrasound assisted synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) benzamide as challenging anti-tubercular scaffold”, Molecules, vol. 23, no. 8, p. Article No: 1945, 2018.
, “Click chemistry based multicomponent approach in the synthesis of spirochromenocarbazole tethered 1,2,3-triazoles as potential anticancer agents”, Bioorganic Chemistry, vol. 85, pp. 475-486, 2019.
, “Design and synthesis of 2-amino-thiophene-proline-conjugates and their anti-tubercular activity against mycobacterium tuberculosis H37Ra”, ChemistrySelect, vol. 4, no. 9, pp. 2851-2857, 2019.
, “Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents”, Bioorganic Chemistry, vol. 86, pp. 507-512, 2019.
, “Evidence of nitrite acting as a stable and robust inducer of non-cultivability in Mycobacterium tuberculosis with physiological relevance”, Scientific Reports, vol. 9, p. 9261, 2019.
, “High content screening assay for identifying inhibitors against active and dormant state intracellular Mycobacterium tuberculosis”, Journal of Microbiological Methods, vol. 164, 2019.
, “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
, “Recursive partitioning analysis and anti-tubercular screening of 3-aminopyrazine-2-carbohydrazide derivatives”, Letters in Drug Design & Discovery, vol. 16, no. 11, pp. 1264-1275, 2019.
, “Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives”, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.
, “Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis”, European Journal of Medicinal Chemistry, vol. 178, pp. 315-328, 2019.
, “Synthesis and biological evaluation of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)phenyl)-2-phenylthiazole derivatives”, Journal of Heterocyclic Chemistry, 2019.
, “Synthesis of new 1,3,4-oxadiazole and benzothiazolylthioether derivatives of 4-arylmethylidene-3-substituted-isoxazol-5(4H)-one as potential antimycobacterial agents”, Medicinal Chemistry Research, vol. 28, no. 11, pp. 1873-1884, 2019.
, “Thiazolyl-pyrazole derivatives as potential antimycobacterial agents”, Bioorganic & Medicinal Chemistry Letters, vol. 29, no. 10, pp. 1199-1202, 2019.
, “Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis”, Plos One, vol. 14, no. 8, p. e0220628, 2019.
, “Anticancer potential of AgNPs synthesized using acinetobacter sp. and curcuma aromatica against HeLa cell lines: a comparative study”, Journal of Trace Elements in Medicine and Biology, vol. 62, p. 126630, 2020.
, “Exploring the pharmacological potentials of biosurfactant derived from planococcus maritimus SAMP MCC 3013”, Current Microbiology, vol. 77, no. 3, pp. 452-459, 2020.
, “Synthesis and antimycobacterial screening of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-3-yl)quinoline derivatives”, Journal of Heterocyclic Chemistry, vol. 57, no. 11, pp. 3918-3929, 2020.
, “2D-QSAR modeling and two-fold classification of 1,2,4-triazole derivatives for antitubercular potency against the dormant stage of Mycobacterium tuberculosis”, Molecular Diversity, vol. 26, no. 2, pp. 1227-1242, 2021.
, “In silico studies, synthesis and antitubercular activity of some novel quinoline - azitidinone derivatives”, Current Computer-Aided Drug Design, vol. 17, no. 1, pp. 134-143, 2021.
, “In vitro antitubercular screening and in silico study of germacradienolide from blainvillea latifolia”, Asian Journal of Chemistry, vol. 33, no. 12, pp. 3129-3133, 2021.
, “Novel gene similar to nitrite reductase (NO forming) plays potentially important role in the latency of tuberculosis”, Scientific Reports, vol. 11, no. 1, p. 19813, 2021.
, “Online tools and antiviral databases for the development of drugs against coronaviruses”, in In Silico Modeling of Drugs Against Coronaviruses: Computational Tools and Protocols, New York, NY: Springer US, 2021, pp. 717–734.
, “Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating Mycobacterium tuberculosis”, Journal of Biomolecular Structure & Dynamics, vol. 39, no. 3, pp. 889-900, 2021.
, “Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocyclyl-2,6-dicyanoanilines (vol 27, pg 979, 2017)”, Bioorganic & Medicinal Chemistry Letters, vol. 32, p. 127737, 2021.
, “Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents”, Bioorganic Chemistry, vol. 115, p. 105192, 2021.
, “Amide-linked monocarbonyl curcumin analogues: efficient synthesis, antitubercular activity and molecular docking study”, Polycyclic Aromatic Compounds, vol. 45, no. 5, pp. 2655-2671, 2022.
, “Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids”, Drug Development Research, vol. 83, no. 2, pp. 416-431, 2022.
, “[DBUH][OAc]-catalyzed domino synthesis of novel benzimidazole incorporated 3,5-Bis (Arylidene)-4-piperidones as potential antitubercular agents”, Polycyclic Aromatic Compounds, vol. 42, no. 10, pp. 7010-7024, 2022.
, “Detection of a target protein (GroEl2) in Mycobacterium tuberculosis using a derivative of 1,2,4-triazolethiols”, Molecular Diversity, vol. 26, no. 5, pp. 2535-2548, 2022.
, “DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium(ii) complexes”, Dalton Transactions, vol. 51, no. 42, pp. 16371-16382, 2022.
, “Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay”, Medicine in Drug Discovery, vol. 13, p. 100115, 2022.
, “Synthesis and antimycobacterial screening of a novel series of alpha-amino acids containing thiazole linker”, ARKIVOC, 2022.
, “Synthesis of new thiazole and pyrazole clubbed 1,2,3-triazol derivatives as potential antimycobacterial and antibacterial agents”, Polycyclic Aromatic Compounds, vol. 42, no. 6, pp. 3216-3237, 2022.
, “Tetrazoloquinoline-1,2,3-triazole derivatives as antimicrobial agents: synthesis, biological evaluation and molecular docking study”, Polycyclic Aromatic Compounds, vol. 42, no. 4, pp. 1920-1941, 2022.
, “Two antibacterial spiro compounds from the roots of Artemisia pallens wall: evidence from molecular docking”, Natural Product Research, vol. 36, no. 10, pp. 2465-2472, 2022.
, “Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid ? (1-42) peptide aggregation”, International Journal of Biological Macromolecules, vol. 239, p. 124197, 2023.
, “Design, synthesis, and in vitro biological evaluation of ROS-generating phenanthridin-trione-epoxide conjugates as agents against mycobacterium tuberculosis”, ChemistrySelect, vol. 8, no. 25, p. e202300416, 2023.
, “Inhibition of amyloid β1-42 peptide aggregation by newly designed cyclometallated palladium complexes”, International Journal of Biological Macromolecules, vol. 248, p. 125847, 2023.
, “Total synthesis, structure elucidation and expanded bioactivity of icosalide A: effect of lipophilicity and ester to amide substitution on its bioactivity”, Organic & Biomolecular Chemistry, vol. 21, no. 28, pp. 5725-5731, 2023.
, “Synthesis and antimicrobial evaluation of novel 2'-aryl-4-aryl-2,4'-Bisthiazole and 2'-aryl-4-Pyridyl-2,4'-bisthiazole derivatives as potential antibacterial agents”, Polycyclic Aromatic Compound , vol. 44, no. 2, pp. 773-787, 2024.
, “Synthesis, biological screening, and molecular docking of hybrid pyrazole scaffolds for antitubercular and antimicrobial activity”, ChemistrySelect, vol. 10, no. 2, p. e202404830, 2025.